1. Home
  2. IMXI vs ANAB Comparison

IMXI vs ANAB Comparison

Compare IMXI & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMXI
  • ANAB
  • Stock Information
  • Founded
  • IMXI N/A
  • ANAB 2005
  • Country
  • IMXI United States
  • ANAB United States
  • Employees
  • IMXI N/A
  • ANAB N/A
  • Industry
  • IMXI Retail: Computer Software & Peripheral Equipment
  • ANAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMXI Technology
  • ANAB Health Care
  • Exchange
  • IMXI Nasdaq
  • ANAB Nasdaq
  • Market Cap
  • IMXI 662.4M
  • ANAB 759.5M
  • IPO Year
  • IMXI N/A
  • ANAB 2017
  • Fundamental
  • Price
  • IMXI $20.68
  • ANAB $14.55
  • Analyst Decision
  • IMXI Buy
  • ANAB Buy
  • Analyst Count
  • IMXI 6
  • ANAB 11
  • Target Price
  • IMXI $27.50
  • ANAB $42.67
  • AVG Volume (30 Days)
  • IMXI 170.9K
  • ANAB 809.3K
  • Earning Date
  • IMXI 11-08-2024
  • ANAB 11-05-2024
  • Dividend Yield
  • IMXI N/A
  • ANAB N/A
  • EPS Growth
  • IMXI 21.49
  • ANAB N/A
  • EPS
  • IMXI 1.80
  • ANAB N/A
  • Revenue
  • IMXI $665,673,000.00
  • ANAB $57,172,000.00
  • Revenue This Year
  • IMXI $2.65
  • ANAB $233.68
  • Revenue Next Year
  • IMXI $3.02
  • ANAB N/A
  • P/E Ratio
  • IMXI $11.52
  • ANAB N/A
  • Revenue Growth
  • IMXI 3.79
  • ANAB 282.17
  • 52 Week Low
  • IMXI $16.17
  • ANAB $14.20
  • 52 Week High
  • IMXI $23.28
  • ANAB $41.31
  • Technical
  • Relative Strength Index (RSI)
  • IMXI 47.16
  • ANAB 30.98
  • Support Level
  • IMXI $21.05
  • ANAB $15.11
  • Resistance Level
  • IMXI $22.30
  • ANAB $16.74
  • Average True Range (ATR)
  • IMXI 0.59
  • ANAB 1.94
  • MACD
  • IMXI -0.17
  • ANAB -0.52
  • Stochastic Oscillator
  • IMXI 7.43
  • ANAB 3.00

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: